entertainment -WSS

entertainment

author：knowledge 2025-09-27 23:54:00 - browse：15718

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Advances in CAR

Wikipedia

WSS

Was Amgen transparent enough on FDA's concern on cancer drug?

What American doctors can learn from their Israeli counterparts

Listen: Biogen's potential pivot, & Illumina's next chapter

A new House health package & hospitals’ new site

FDA authorizes Novavax’s updated Covid

Stem cell treatment guidelines are released by FDA

explore

entertainment

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Colorectal cancer study finds potential in overlooked immune cell

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicaid rebukes states for mistakenly disenrolling children

Walensky prepares to leave CDC — and Congress — behind

ALS advocates say criticism of new drugs misses bigger picture

Walensky prepares to leave CDC — and Congress — behind

Why Novartis is changing the name of its research labs

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AstraZeneca chief proposes a novel edit to the drug pricing bill

leisure time

Weighted lottery helped low

The 10 drugs up first for Medicare price negotiation

Stem cell treatment guidelines are released by FDA

Chemotherapy drug shortage eases slightly but still widespread

Chemotherapy drug shortage eases slightly but still widespread

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Wikipedia

leisure time

hotspot

focus